• Aamer Aleem, Faisal Alsayegh, Satish Keshav, Abdulrahman Alfadda, Ahmad Awad Alfadhli, Abdulrahman Al-Jebreen, Fawaz Al-Kasim, Ali Almuhaini, Hazzaa Al-Zahrani, Faisal Batwa, Srdjan Denic, Ahmad Jazzar, Tarek Owaidah, Mohamad Qari, Yousef Qari, and Mazen Taha.
• Department of Medicine, Division of Hematology/Oncology, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia, ameralem@ksu.edu.sa.
• Med Princ Pract. 2020 Jan 1; 29 (4): 371-381.

BackgroundIron deficiency (ID) and ID anemia (IDA) are common in the member states of the Gulf Cooperation Council (GCC). The unique genetic and lifestyle factors of the patient population in the region have necessitated the development of recommendations to help educate health-care professionals on appropriate diagnosis and management of ID/IDA.MethodsA panel of regional experts, including gastroenterologists and hematologists with expertise in the treatment of IDA, was convened to develop regional practice recommendations for ID/IDA. After reviewing the regional and international literature, the expert panel developed consensus recommendations for screening, diagnosis, and treatment of patients with IDA in the GCC region.ResultsThe recommendations proposed were customized to the patient population keeping in view the increasingly recognized burden of coeliac disease, high fertility and obesity rates, high prevalence of alpha- and beta-thalassemia traits, and poor tolerance and low treatment compliance with oral iron therapy.ConclusionsThis consensus statement proposes recommendations for screening, diagnosis, and treatment of IDA in the GCC region.© 2019 The Author(s) Published by S. Karger AG, Basel.

26 keywords...

hide…